Danielle Golay

Danielle Golay is a dedicated leader in the drug manufacturing industry, currently serving as Vice President of the Biologics and Cell & Gene Therapy Q Unit at Bayer. With a background that includes significant roles at Genentech, Exelixis, and Lyell Immunopharma, Danielle has championed quality operations and compliance across various biopharmaceutical sectors. They hold a Master's degree in Information Technology from Capella University and a Bachelor's degree in Business Administration with an emphasis on Information Systems from the University of Southern California. Danielle's commitment to developing curative therapies is driven by personal experiences and a passion for helping others achieve seemingly impossible goals.